The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | 500,080 | 19,766 | SH | SOLE | 0 | 0 | 19,766 | ||
| ALKERMES PLC | SHS | G01767105 | 314,370 | 6,000 | SH | SOLE | 0 | 0 | 6,000 | ||
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 441,009 | 1,465 | SH | SOLE | 0 | 0 | 1,465 | ||
| AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 194,650 | 10,838 | SH | SOLE | 0 | 0 | 10,838 | ||
| ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 516,534 | 19,700 | SH | SOLE | 0 | 0 | 19,700 | ||
| ARDELYX INC | COM | 039697107 | 306,000 | 60,000 | SH | SOLE | 0 | 0 | 60,000 | ||
| ARGENX SE | SPONSORED ADR | 04016X101 | 594,701 | 641 | SH | SOLE | 0 | 0 | 641 | ||
| ARRIVENT BIOPHARMA INC | COM | 04272N102 | 244,604 | 7,041 | SH | SOLE | 0 | 0 | 7,041 | ||
| ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 211,926 | 2,600 | SH | SOLE | 0 | 0 | 2,600 | ||
| ASCENDIS PHARMA A/S | ORD SHS | K08588103 | 400,080 | 1,500 | SH | SOLE | 0 | 0 | 1,500 | ||
| AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 509,100 | 30,000 | SH | SOLE | 0 | 0 | 30,000 | ||
| AXSOME THERAPEUTICS INC. | COM | 05464T104 | 244,770 | 1,000 | SH | SOLE | 0 | 0 | 1,000 | ||
| BRIDGEBIO PHARMA INC | COM | 10806X102 | 223,440 | 3,000 | SH | SOLE | 0 | 0 | 3,000 | ||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 483,730 | 13,000 | SH | SOLE | 0 | 0 | 13,000 | ||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 464,400 | 12,000 | SH | SOLE | 0 | 0 | 12,000 | ||
| COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 254,700 | 18,000 | SH | SOLE | 0 | 0 | 18,000 | ||
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 411,620 | 11,000 | SH | SOLE | 0 | 0 | 11,000 | ||
| CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 272,700 | 5,000 | SH | SOLE | 0 | 0 | 5,000 | ||
| CYTOMX THERAPEUTICS INC. | COM | 23284F105 | 147,750 | 39,400 | SH | SOLE | 0 | 0 | 39,400 | ||
| DEFINIUM THERAPEUTICS INC | COM SHS | 24477V105 | 470,400 | 10,000 | SH | SOLE | 0 | 0 | 10,000 | ||
| DENALI THERAPEUTICS INC | COM | 24823R105 | 217,668 | 8,463 | SH | SOLE | 0 | 0 | 8,463 | ||
| DIANTHUS THERAPEUTICS INC | COM | 252828108 | 243,700 | 2,500 | SH | SOLE | 0 | 0 | 2,500 | ||
| DISC MEDICINE INC | COM | 254604101 | 585,120 | 8,000 | SH | SOLE | 0 | 0 | 8,000 | ||
| DYNE THERAPEUTICS INC | COM | 26818M108 | 444,200 | 20,000 | SH | SOLE | 0 | 0 | 20,000 | ||
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 203,150 | 5,000 | SH | SOLE | 0 | 0 | 5,000 | ||
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 355,250 | 7,000 | SH | SOLE | 0 | 0 | 7,000 | ||
| EXELIXIS INC | COM | 30161Q104 | 435,280 | 8,000 | SH | SOLE | 0 | 0 | 8,000 | ||
| EYEPOINT INC | COM NEW | 30233G209 | 143,000 | 10,000 | SH | SOLE | 0 | 0 | 10,000 | ||
| HALOZYME THERAPEUTICS INC | COM | 40637H109 | 547,890 | 7,000 | SH | SOLE | 0 | 0 | 7,000 | ||
| HARMONY BIOSCIENCES HLDGS IN | COM | 413197104 | 364,100 | 10,000 | SH | SOLE | 0 | 0 | 10,000 | ||
| IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 480,727 | 15,141 | SH | SOLE | 0 | 0 | 15,141 | ||
| IMMUNOME INC | COM | 45257U108 | 381,420 | 18,000 | SH | SOLE | 0 | 0 | 18,000 | ||
| IMMUNOVANT INC | COM | 45258J102 | 500,890 | 13,000 | SH | SOLE | 0 | 0 | 13,000 | ||
| INCYTE CORP | COM | 45337C102 | 600,808 | 5,300 | SH | SOLE | 0 | 0 | 5,300 | ||
| INTELLIA THERAPEUTICS INC | COM | 45826J105 | 338,400 | 20,000 | SH | SOLE | 0 | 0 | 20,000 | ||
| IONIS PHARMACEUTICALS INC | COM | 462222100 | 539,172 | 6,800 | SH | SOLE | 0 | 0 | 6,800 | ||
| ISHARES TR | 0-3 MTH TREASURY | 46436E718 | 70,469,000 | 700,000 | SH | SOLE | 0 | 0 | 700,000 | ||
| JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | 233,982 | 971 | SH | SOLE | 0 | 0 | 971 | ||
| KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | G52694109 | 319,750 | 5,000 | SH | SOLE | 0 | 0 | 5,000 | ||
| KODIAK SCIENCES INC | COM | 50015M109 | 233,760 | 6,000 | SH | SOLE | 0 | 0 | 6,000 | ||
| KRYSTAL BIOTECH INC | COM | 501147102 | 257,196 | 692 | SH | SOLE | 0 | 0 | 692 | ||
| KYMERA THERAPEUTICS INC | COM | 501575104 | 458,680 | 4,000 | SH | SOLE | 0 | 0 | 4,000 | ||
| LIQUIDIA CORPORATION | COM NEW | 53635D202 | 398,650 | 5,000 | SH | SOLE | 0 | 0 | 5,000 | ||
| MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 322,170 | 600 | SH | SOLE | 0 | 0 | 600 | ||
| MIRUM PHARMACEUTICALS INC | COM | 604749101 | 292,675 | 2,500 | SH | SOLE | 0 | 0 | 2,500 | ||
| MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | 556,600 | 23,000 | SH | SOLE | 0 | 0 | 23,000 | ||
| NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 505,605 | 3,000 | SH | SOLE | 0 | 0 | 3,000 | ||
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 406,680 | 12,000 | SH | SOLE | 0 | 0 | 12,000 | ||
| NURIX THERAPEUTICS INC | COM | 67080M103 | 606,500 | 25,000 | SH | SOLE | 0 | 0 | 25,000 | ||
| OCULAR THERAPEUTIX INC | COM | 67576A100 | 147,300 | 15,000 | SH | SOLE | 0 | 0 | 15,000 | ||
| OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 125,100 | 10,000 | SH | SOLE | 0 | 0 | 10,000 | ||
| ORIC PHARMACEUTICALS INC | COM | 68622P109 | 140,790 | 13,000 | SH | SOLE | 0 | 0 | 13,000 | ||
| ORUKA THERAPEUTICS INC | COM | 687604108 | 285,510 | 3,000 | SH | SOLE | 0 | 0 | 3,000 | ||
| PHARVARIS N V | COM | N69605108 | 518,700 | 15,000 | SH | SOLE | 0 | 0 | 15,000 | ||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 367,740 | 3,000 | SH | SOLE | 0 | 0 | 3,000 | ||
| PTC THERAPEUTICS INC | COM | 69366J200 | 489,420 | 6,000 | SH | SOLE | 0 | 0 | 6,000 | ||
| RAPPORT THERAPEUTICS INC | COM | 75383L102 | 583,380 | 14,000 | SH | SOLE | 0 | 0 | 14,000 | ||
| REVOLUTION MEDICINES INC | COM | 76155X100 | 224,736 | 1,200 | SH | SOLE | 0 | 0 | 1,200 | ||
| RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 222,060 | 2,000 | SH | SOLE | 0 | 0 | 2,000 | ||
| ROYALTY PHARMA PLC | SHS CLASS A | G7709Q104 | 616,770 | 11,000 | SH | SOLE | 0 | 0 | 11,000 | ||
| SCHOLAR ROCK HLDG CORP | COM | 80706P103 | 210,485 | 3,827 | SH | SOLE | 0 | 0 | 3,827 | ||
| SPDR SERIES TRUST | ST STR SP BIOT | 78464A870 | 90,202,500 | 570,000 | SH | SOLE | 0 | 0 | 570,000 | ||
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 355,120 | 4,000 | SH | SOLE | 0 | 0 | 4,000 | ||
| STOKE THERAPEUTICS INC | COM | 86150R107 | 392,640 | 12,000 | SH | SOLE | 0 | 0 | 12,000 | ||
| SUPERNUS PHARMACEUTICALS | COM | 868459108 | 279,060 | 6,000 | SH | SOLE | 0 | 0 | 6,000 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 437,200 | 20,000 | SH | SOLE | 0 | 0 | 20,000 | ||
| TANGO THERAPEUTICS INC | COM | 87583X109 | 312,600 | 10,000 | SH | SOLE | 0 | 0 | 10,000 | ||
| TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 440,580 | 7,000 | SH | SOLE | 0 | 0 | 7,000 | ||
| TG THERAPEUTICS INC | COM | 88322Q108 | 549,400 | 10,000 | SH | SOLE | 0 | 0 | 10,000 | ||
| TREVI THERAPEUTICS INC | COM | 89532M101 | 559,500 | 30,000 | SH | SOLE | 0 | 0 | 30,000 | ||
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 567,630 | 17,000 | SH | SOLE | 0 | 0 | 17,000 | ||
| VERA THERAPEUTICS INC | CL A | 92337R101 | 300,370 | 7,000 | SH | SOLE | 0 | 0 | 7,000 | ||
| VIKING THERAPEUTICS INC | COM | 92686J106 | 390,100 | 10,000 | SH | SOLE | 0 | 0 | 10,000 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 253,512 | 4,200 | SH | SOLE | 0 | 0 | 4,200 | ||
| ZYMEWORKS INC | COM | 98985Y108 | 261,400 | 10,000 | SH | SOLE | 0 | 0 | 10,000 | ||